AtriCure Announces February Investor Conference Schedule

Published on Thursday, 09 February 2012 12:05 Written by TradersHuddle Staff

WEST CHESTER, Ohio-( Business Wire )-

AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in cardiac surgical ablation systems and systems for the exclusion of the left atrial appendage, today announced that it will participate in the following upcoming investor conferences:

• The Leerink Swann 2012 Global Healthcare Conference at the Waldorf Astoria hotel in New York. Management is scheduled to present on Thursday, February 16, 2012 at 11:30 a.m. Eastern Time.
• The 2012 RBC Capital Markets Global Healthcare Conference at the New York Palace hotel in New York. Management is scheduled to present on Tuesday, February 28, 2012 at 10:00 a.m. Eastern Time.

A live audio webcast and replay of the presentations will be available for 30 days following the events at www.atricure.com.

About AtriCure, Inc.

AtriCure, Inc. is a medical device company and a leader in developing, manufacturing and selling innovative cardiac surgical ablation systems designed to create precise lesions, or scars, in cardiac, or heart, tissue for the treatment of atrial fibrillation, or AF, and systems for the exclusion of the left atrial appendage. For more information, please visit www.atricure.com.

AtriCure, Inc.Julie A. Piton, Vice President and Chief Financial Officer, This e-mail address is being protected from spambots. You need JavaScript enabled to view it.